ALKBH5 modulates m6A modification to enhance acute myeloid leukemia resistance to adriamycin. Biomol Biomed [Internet]. 2024 Oct. 27 [cited 2025 Nov. 1];25(5):1038–1051. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11076